Population-scale genomic medicine with the Hong Kong Genome Project
Sequencing 20,000 people reveals genomic medicine can help diagnose rare diseases in Chinese populations that European-only panels often miss.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Multicentric data challenge for artificial intelligence-based…
AI models trained on 69,000 blood cell images now classify white blood cells nearly as accurately as human experts, potentially speeding up diagnoses.
Near-term implementable findingEffects of glucagon-like peptide-1 receptor agonists and dual…
Diabetes medications called GLP-1 agonists measurably shrink fatty liver and reduce liver scarring in patients with metabolic disease.
Near-term implementable findingCardiometabolic associations of SGLT-2 inhibitors on epicardial…
SGLT-2 inhibitor diabetes drugs reduce harmful belly fat around the heart and improve heart function in Asian patients with coronary disease.
Novel or significantly improved treatmentCD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for…
Novel CAR-T cell therapy successfully removes dangerous antibodies before transplant in patients previously ineligible for life-saving bone marrow donation.